Lorraine Reverson Ray

Lorraine Ray practices at Rscr Inland, Inc. in Redlands, California.

Lorraine Ray's NPI, 1295179620, was assigned on April 29, 2013. Lorraine Ray graduated from Loma Linda University School Of Medicine in 2013. Lorraine Ray's California license number on file is 150249.

Lorraine Ray's primary practice is Rscr Inland, Inc., at 625 Amigos Dr, Redlands, CA 92373 in San Bernardino County. The practice phone is (951) 788-2562.

Lorraine Ray's primary practice is Rscr Inland, Inc. in Redlands, California. Lorraine Ray is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Lorraine Ray to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lorraine Ray practices, 2 sites in all. Vendor and product names are available with a free account.

Pediatrics is Lorraine Ray's primary specialty in the NPI Registry, under taxonomy code 208000000X. Lorraine Ray is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Lorraine Ray's licenses on file in 2 states: California and Kentucky.

Dmand AI lists acid reflux, acute sinusitis, chronic diabetes, chronic hypertension, chronic nasal allergies, contact dermatitis, ear infection and high cholesterol among the conditions Lorraine Ray treats.

CMS data shows 197 Medicare services from Lorraine Ray across 3 procedure codes in 2024, for 81 Medicare patients. Medicare paid $12,164 for them. Every service was in an office.

CMS counts 81 Medicare patients who saw Lorraine Ray in 2024. The largest group is 65 to 74, with 33 patients. 73% of them have high cholesterol, and 54% have high blood pressure. 83% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Lorraine Ray's median patient age at 17, with 57% women.

In 2024, Lorraine Ray wrote 2,325 Medicare Part D claims for 136 patients. 85% of them were for generic drugs. CMS names the drug for 1,853 of them, across 51 drugs with 11 or more claims each, at $59,585 in total drug cost. In 2023, CMS named 1,983 claims across 63 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Lorraine Ray for performance year 2024, reported as part of a group. Lorraine Ray accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lorraine Ray as offering telehealth.

Dmand AI links 8 papers to Lorraine Ray, published from 2012 to 2019. 2014 was the busiest year, with 2. The most frequent topics are Drosophila Proteins, Drosophila melanogaster and Animals, Genetically Modified. Lorraine Ray has published most often in Blood Adv. Lorraine Ray's most frequent co-authors are Michael Sean Grimley, MD, Jeremy D. Rubinstein and Catherine Bollard, MD.

CMS Open Payments shows 11 general payments to Lorraine Ray from 5 drug and device companies from 2018 to 2022. Food and beverage make up the largest share, 100% of the total. Sobi, Inc paid the most, $74.

Lorraine Ray graduated from Loma Linda University School Of Medicine in 2013.

Lorraine Ray is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.